Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fayza Eid Nasr"'
Autor:
Nermeen Z. Abuelezz, Fayza Eid Nasr, Mohammad Ahmed AbdulKader, Ahmad R. Bassiouny, Amira Zaky
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Alzheimer's disease (AD) is a progressive and deleterious neurodegenerative disease, strongly affecting the cognitive functions and memory of seniors worldwide. Around 58% of the affected patients live in low and middle-income countries, with estimat
Externí odkaz:
https://doaj.org/article/94bbcafd434d4dd8b9e7fd7cd9455e31
Publikováno v:
Experimental gerontology. 169
Till date, there is an obvious obscurity of specific and early diagnostic biomarkers for Alzheimer's disease (AD). The promising diagnostic potential of serum miRNAs is increasingly emerging; however, rare miRNAs data originates from middle and low-i
Publikováno v:
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience, Vol 13 (2021)
Frontiers in Aging Neuroscience, Vol 13 (2021)
Alzheimer's disease (AD) is a progressive and deleterious neurodegenerative disease, strongly affecting the cognitive functions and memory of seniors worldwide. Around 58% of the affected patients live in low and middle-income countries, with estimat
Autor:
Umar Ahmad, B. W. Goni, Abdulbasit Amin, Idris A. Azeez, H. A. Ibrahim, S. K. Hamidu, Abdulbasit Haliru Yakubu, Lucia L. Prieto-Godino, Tom Baden, Yunusa Garba Mohammed, A. U. Yaro, Ali Maina Bukar, M. A. Awadelkareem, Fayza Eid Nasr, Mahmoud Bukar Maina, Hadziroh Ibrahim, A. T. Salihu, Ibukun Akinrinade, Abdelrahman Ibrahim Abushouk, M. Abdurrazak, Aminu Imam, Abdu A. Adamu
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications
Nature Communications
Neuroscience research in Africa remains sparse. Devising new policies to boost Africa’s neuroscience landscape is imperative, but these must be based on accurate data on research outputs which is largely lacking. Such data must reflect the heteroge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d3319f270780c5253462375ff816c2
https://www.repository.cam.ac.uk/handle/1810/323578
https://www.repository.cam.ac.uk/handle/1810/323578
Autor:
Lucia L. Prieto-Godino, Abdu A. Adamu, H. A. Ibrahim, Abdulbasit Amin, GM Yunusa, M. Abdurrazak, Ali Maina Bukar, Mahmoud Bukar Maina, Hadziroh Ibrahim, A. T. Salihu, Tom Baden, M. A. Awadelkareem, Fayza Eid Nasr, Ibukun Akinrinade, Umar Ahmad, S. K. Hamidu, Abdulbasit Haliru Yakubu, Aminu Imam, A. U. Yaro, Idris A. Azeez, Abdelrahman Ibrahim Abushouk
Publikováno v:
bioRxiv
Understanding the function and dysfunction of the brain remains one of the key challenges of our time. However, an overwhelming majority of brain research is carried out in the Global North, by a minority of well-funded and intimately interconnected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4cb78ff3f08aa2c43236701c339a606
Autor:
Umar Ahmad, Tom Baden, Ali Maina Bukar, Harun A. Ibrahim, M. A. Awadelkareem, Aisha Umar Yaro, Mahmoud Bukar Maina, Abubakar Tijjani Salihu, Yunusa Garba Mohammed, Fayza Eid Nasr, Muhammad Abdurrazak, Suleiman Kwairanga Hamidu
Publikováno v:
European Journal of Neuroscience
Of the 572 neuroscience-related studies published in Nigerian from 1996 to 2017
Autor:
Maina, Mahmoud Bukar1,2 (AUTHOR) m.bukar-maina@sussex.ac.uk, Mohammed, Yunusa Garba2,3 (AUTHOR), Bukar, Ali Maina4 (AUTHOR), Ahmad, Umar5,6 (AUTHOR), Tijjani Salihu, Abubakar7 (AUTHOR), Ibrahim, Harun A.8 (AUTHOR), Abdurrazak, Muhammad9 (AUTHOR), Hamidu, Suleiman Kwairanga2 (AUTHOR), Yaro, Aisha Umar10 (AUTHOR), Awadelkareem, Mosab Ali11 (AUTHOR), Nasr, Fayza Eid12 (AUTHOR), Baden, Tom1 (AUTHOR)
Publikováno v:
European Journal of Neuroscience. Jun2019, Vol. 49 Issue 12, p1544-1551. 8p. 1 Chart, 4 Graphs.
Autor:
Abuelezz, Nermeen Z., Nasr, Fayza Eid, AbdulKader, Mohammad Ahmed, Bassiouny, Ahmad R., Zaky, Amira
Publikováno v:
Frontiers in Aging Neuroscience; 10/12/2021, Vol. 13, p1-26, 26p
Autor:
Wael Mohamed
Due to the lack of secure, efficient, and patient-friendly therapies for neurodegenerative disorders, there is a rising demand for innovative approaches. Despite the limited number of nanocarriers approved for human use, they have demonstrated signif